返回
BioArctic AB (BRCTF) 收益
BRCTF 股價走勢圖
BRCTF 收益
BioArctic AB
$33.02
0%
$0
收盤價：Mar 24, 16:00:00 GMT-4
$33.02
0%
$0
盤前：Mar 25, 06:58:32 GMT-4
關鍵數據
前收市價
$33.02
開盤價
$38
當日範圍
$33.02 - $38
52週區間
$15.49 - $36.83
交易量
200
平均成交量
87
股息收益率
--
每股盈餘 (TTM)
1.22
市值
$2.4B
什麼是 BIOARCTIC AB？
BioArctic AB engages in the research and development of modifying treatments and diagnostics for neurodegenerative diseases. The company is headquartered in Stockholm, Stockholm and currently employs 131 full-time employees. The company went IPO on 2017-10-12. The firm focuses on the research and development of treatments, which aim at diseases that affect the central nervous system (CNS). Its therapeutic areas encompass neurodegenerative disorders, Alzheimer's disease, Parkinson's disease, complete spinal cord injury, as well as other CNS disorders. The firm owns a technology platform, which develops a range of therapeutic monoclonal antibodies. The firm's pipeline includes product candidates in various clinical phases, such as BAN2401, AE1501, BAN0805, imaging and biochemical biomarkers, BBB-technology and SC0806. The firm also operates through SpineMedical AB.